Author:
Yan Sijia,Xiong Hao,Shao Fengmin,Zhang Wen,Yang Fanping,Qi Zheng,Chen Shengan,He Lin,Jiang Menglin,Su Yu,Zhu Huizhong,Qin Shengying,Zhu Qinyuan,Luo Xiaoqun,Xing Qinghe
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology,Genetics,Molecular Medicine
Reference47 articles.
1. Zhang X, Wu J, Zhang B. Xuesaitong injection as one adjuvant treatment of acute cerebral infarction: a systematic review and meta-analysis. BMC Complem Altern. 2015;15:36.
2. Yao DL. Curative effect of Xuesaitong injection on acute cerebral infarction of 50 patients. Prac Clin Med. 2007;12:21–2.
3. Yang PF, Song XY, Chen NH. Advances in pharmacological studies of Panax notoginseng saponins on brain ischemia-reperfusion injury. Acta Pharm Sin. 2016;51:1039–46.
4. He W, Xu XJ. Attenuation of brain inflammatory response after focal cerebral ischemia/reperfusion with Xuesaitong injection in rats. CHIN J INTEGR MED/1234. 2006;12:203–6.
5. Wang L, Li Z, Zhao X, Liu W, Liu Y, Yang J, et al. A network study of chinese medicine xuesaitong injection to elucidate a complex mode of action with multicompound, multitarget, and multipathway. Evid-Based Complement Altern Med. 2013;2013:652373.